It is a onetime dose of IV medication administered as soon as possible after a confirmed diagnosis of COVID-19. With monoclonal antibody therapy, physicians now have a way to help prevent severe symptoms from developing in patients who are at a high risk.
WHAT IS BAM TREATMENT?
- Monoclonal antibodies are laboratory made proteins that mimic the immune system’s ability to fight off harmful pathogens.
- Monoclonal antibody-based therapies have the greatest likelihood of having an impact in the earliest stages of infection before an effective immune response has been triggered.
- The therapy is a one time dose of IV medication that should be administered as soon as possible after a confirmed diagnosis of COVID-19 and within 10 days of the first onset of symptoms.
WHO CAN BENEFIT?
- Patients with mild to moderate COVID-19 who are at high risk for progressing to severe COVID-19 and/or hospitalization.
- Patient must not currently be hospitalized.
- Patient must not currently require increased oxygen due to COVID infection.
- Patient must be at high risk for progressing to severe COVID-19 and/or hospitalization which is defined as age >/=65 yrs and those </+ 55 years with underlying illnesses.
WHY INPATIENT RECOVERY?
- The elderly and/or individuals with co-morbidities may be more impacted by Covid-19. Often their weakened conditions are unmanageable in their home environment due to existing or lacking social support.
- Recovery in a skilled nursing environment allows the individual to receive treatment and regain strength with the support of a licensed team of nurses and therapists.
- Inpatient medical oversight by primary and specialty physicians provides valuable medical support an individual may not receive in their home setting.
HOW DO I REFER A PATIENT?
- For expedited patient qualification and admission arrangements, contact Millie Santiago 610.742.2669 or Kim Turoski 215.280.0191
- Same Day Admissions can occur with qualified patient cases.